Sign in
Stories
Edison System Revolutionizes Liver Tumor Treatment
Share
Advances in Brain Cancer Treatments
HistoSonics Initiates Renal Tumor Treatm...
Overview
API
HistoSonics, a manufacturer of the non-invasive histotripsy system Edison, has achieved a significant milestone by treating the first patient for liver tumors at the University of Rochester Medical Center. The FDA has authorized the system for liver tumor treatment, indicating the potential of this technology to revolutionize clinical practice.
Ask a question
How might the non-invasive Edison system impact other surgical procedures?
What are the broader implications of this technology on the healthcare industry?
What are the potential challenges or limitations associated with the Edison system?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage